• Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Consensus Recommendation of "Buy" by Analysts

    المصدر: Buzz FX / 29 ديسمبر 2024 04:21:13   America/New_York


    Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Consensus Recommendation of "Buy" by Analysts Written by MarketBeat December 29, 2024 Share Link copied to clipboard. Shares of Spyre Therapeutics, Inc. ( NASDAQ:SYRE - Get Free Report ) have bee
    Read more...
شارك على،